Indeed, a number of drugs with bioelectric targets, such as ivermectin (a chloride channel drug) [126,127,128,129], salinomycin and monensin (ionophores) [126,130], a variety of potassium channel drugs [25,55,131,132,133,134], and drugs targeting proton pumps [135] have been discovered to have anti-cancer activity in various screens [26,136,137,138,139]. Here, KCNA3 is linked to cancer.